CLINICAL BIOCHEMISTRY, vol.44, no.12, pp.955-958, 2011 (Peer-Reviewed Journal)
Article / Article
Science Citation Index Expanded, Scopus
Galectin-3, Nonalcoholic fatty liver disease, Enzyme-linked immunosorbent assay, Biopsy, METABOLIC SYNDROME, STEATOHEPATITIS, ASSOCIATION, OBESITY, MICE
Objectives: Galectin-3 might serve as a biomarker of human metabolic alterations. We measured serum levels of galectin-3 in patients with nonalcoholic fatty liver disease (NAFLD) and examined their association with clinical and histological phenotypes.